Virtu Financial LLC Avadel Pharmaceuticals PLC Transaction History

Virtu Financial LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.3 - $15.99 $206,484 - $320,551	20,047 New	20,047 $206,000
Q1 2023 May 01, 2023	BUY	$6.41 - $9.95 $9,288 - $14,417	1,449 Added 9.46%	16,759 $154,000
Q4 2022 Feb 15, 2023	BUY	$5.02 - $10.0 $23,940 - $47,690	4,769 Added 45.24%	15,310 $110,000
Q3 2022 Nov 07, 2022	BUY	$2.57 - $7.31 $27,090 - $77,054	10,541 New	10,541 $53,000
Q1 2022 May 17, 2022	SELL	$5.46 - $8.29 $138,831 - $210,789	-25,427 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$7.34 - $11.18 $186,634 - $284,273	25,427 New	25,427 $205,000
Q1 2021 May 19, 2021	SELL	$6.61 - $10.07 $95,587 - $145,622	-14,461 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$5.03 - $7.95 $72,738 - $114,964	14,461 New	14,461 $97,000
Q3 2020 Dec 11, 2020	SELL	$5.02 - $8.98 $165,900 - $296,771	-33,048 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$7.25 - $11.75 $239,598 - $388,314	33,048 New	33,048 $267,000
Q1 2018 May 14, 2018	SELL	$6.76 - $11.7 $87,602 - $151,620	-12,959 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$8.03 - $11.25 $1,999 - $2,801	-249 Reduced 1.89%	12,959 $106,000
Q3 2017 Nov 15, 2017	BUY	$8.35 - $10.5 $110,286 - $138,684	13,208	13,208 $0

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.